🟢 Neuronetics is trading 5.61% up today after B. Riley initiated Buy coverage

Neuronetics is trading 5.61% up at $3.21 after B. Riley initiated Buy coverage on September 11, 2026, with a $5.00 price target.

• The analyst cited Greenbrook’s growth potential, operating leverage, and Neuronetics’ repositioning as an interventional-psychiatry platform.
• The recommendation represents roughly 66%-70% potential upside from recent levels and appears to be supporting continued buying interest during the September 14 session.